PRELUDE CAPITAL MANAGEMENT, LLC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 74 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$97,995
-30.3%
15,053
-8.7%
0.01%
-14.3%
Q4 2022$140,651
+35.2%
16,489
-16.3%
0.01%
+75.0%
Q3 2022$104,000
-41.2%
19,694
-52.8%
0.00%
-20.0%
Q2 2022$177,000
+48.7%
41,700
+22.6%
0.01%
+66.7%
Q1 2022$119,000
+7.2%
34,000
+103.6%
0.00%0.0%
Q4 2021$111,00016,7000.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$26,123,9999.73%
Nextech Invest Ltd. 1,910,029$12,434,2895.19%
K2 PRINCIPAL FUND, L.P. 2,686,490$17,489,0512.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$72,117,3051.61%
Orbimed Advisors 8,740,887$56,903,1741.12%
SECTORAL ASSET MANAGEMENT INC 793,587$5,166,2510.99%
Tejara Capital Ltd 207,555$1,351,1830.69%
Rubric Capital Management LP 3,480,712$22,659,4350.59%
Resolute Capital Asset Partners LLC 120,000$7810.57%
RA Capital Management 3,009,678$19,593,0040.44%
View complete list of SILVERBACK THERAPEUTICS INC shareholders